Goldman Sachs’s Cogent Biosciences COGT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $171M | Buy |
4,434,054
+2,728,910
| +160% | +$101M | 0.02% | 748 |
|
|
2025
Q4 | $60.6M | Buy |
1,705,144
+45,467
| +3% | +$1.28M | 0.01% | 1348 |
|
|
2025
Q3 | $23.8M | Buy |
1,659,677
+459,240
| +38% | +$5.44M | ﹤0.01% | 2098 |
|
|
2025
Q2 | $8.62M | Buy |
1,200,437
+211,475
| +21% | +$1.17M | ﹤0.01% | 2890 |
|
|
2025
Q1 | $5.92M | Buy |
988,962
+124,069
| +14% | +$973K | ﹤0.01% | 3184 |
|
|
2024
Q4 | $6.75M | Sell |
864,893
-13,144
| -1% | -$131K | ﹤0.01% | 3159 |
|
|
2024
Q3 | $9.48M | Buy |
878,037
+364,290
| +71% | +$3.55M | ﹤0.01% | 2787 |
|
|
2024
Q2 | $4.33M | Sell |
513,747
-357,450
| -41% | -$2.71M | ﹤0.01% | 3290 |
|
|
2024
Q1 | $5.85M | Buy |
871,197
+424,425
| +95% | +$2.62M | ﹤0.01% | 2947 |
|
|
2023
Q4 | $2.63M | Buy |
446,772
+46,890
| +12% | +$359K | ﹤0.01% | 3709 |
|
|
2023
Q3 | $3.9M | Buy |
399,882
+35,048
| +10% | +$416K | ﹤0.01% | 3208 |
|
|
2023
Q2 | $4.32M | Sell |
364,834
-188,896
| -34% | -$2.17M | ﹤0.01% | 3229 |
|
|
2023
Q1 | $5.97M | Sell |
553,730
-92,007
| -14% | -$1.18M | ﹤0.01% | 2891 |
|
|
2022
Q4 | $7.46M | Sell |
645,737
-96,251
| -13% | -$1.19M | ﹤0.01% | 2833 |
|
|
2022
Q3 | $11.1M | Buy |
741,988
+372,063
| +101% | +$5.1M | ﹤0.01% | 2415 |
|
|
2022
Q2 | $3.34M | Buy |
369,925
+190,892
| +107% | +$1.3M | ﹤0.01% | 3570 |
|
|
2022
Q1 | $1.34M | Buy |
179,033
+99,874
| +126% | +$696K | ﹤0.01% | 4591 |
|
|
2021
Q4 | $679K | Sell |
79,159
-70,534
| -47% | -$613K | ﹤0.01% | 5147 |
|
|
2021
Q3 | $1.26M | Buy |
+149,693
| New | +$1.15M | ﹤0.01% | 4570 |
|
|
2021
Q2 | – | Sell |
-38,882
| Closed | -$341K | – | 6233 |
|
|
2021
Q1 | $341K | Buy |
38,882
+28,569
| +277% | +$275K | ﹤0.01% | 5354 |
|
|
2020
Q4 | $116K | Buy |
10,313
+2,188
| +27% | +$24K | ﹤0.01% | 5268 |
|
|
2020
Q3 | $76K | Sell |
8,125
-2,305
| -22% | -$24K | ﹤0.01% | 5127 |
|
|
2020
Q2 | $19K | Hold |
10,430
| – | – | ﹤0.01% | 5129 |
|
|
2020
Q1 | $17K | Sell |
10,430
-1,154
| -10% | -$3.21K | ﹤0.01% | 5141 |
|
|
2019
Q4 | $33K | Sell |
11,584
-14,290
| -55% | -$58.3K | ﹤0.01% | 5147 |
|
|
2019
Q3 | $149K | Buy |
25,874
+11,227
| +77% | +$91.3K | ﹤0.01% | 4901 |
|
|
2019
Q2 | $153K | Buy |
14,647
+10,664
| +268% | +$142K | ﹤0.01% | 4860 |
|
|
2019
Q1 | $70K | Sell |
3,983
-1,373
| -26% | -$23.5K | ﹤0.01% | 4972 |
|
|
2018
Q4 | $94K | Buy |
5,356
+2,205
| +70% | +$65.2K | ﹤0.01% | 5006 |
|
|
2018
Q3 | $130K | Sell |
3,151
-4,760
| -60% | -$268K | ﹤0.01% | 5054 |
|
|
2018
Q2 | $454K | Sell |
7,911
-5,538
| -41% | -$266K | ﹤0.01% | 4563 |
|
|
2018
Q1 | $598K | Buy |
+13,449
| New | +$598K | ﹤0.01% | 4374 |
|
Other funds holding COGT
DM
VPM
VCM
FFM
RI
TCM